Jiangsu Haiyuekang Pharmaceutical Technology Co., Ltd., located in the Science and Technology Innovation Park of Binhai New District, Haimen City, Jiangsu Province, is a high-tech enterprise dedicated to the research and development of new drugs and generic drugs. The company has extensive experience in various fields, including intermediates, active pharmaceutical ingredients (APIs), formulations, analytical method development and validation, as well as the research and establishment of quality standards, and the application for new drugs and generic drugs. The company has established core departments such as the Synthesis Department, Formulation Department, Analytical Department, Information and Project Initiation Department, and Drug Registration Department, and has a complete project management system covering information research, project initiation, development, and application. The management team possesses strong R&D backgrounds and years of management experience, committed to building the company into a leading enterprise in domestic drug research and development.

The company covers a total area of over 3,000 square meters and is equipped with advanced and comprehensive R&D equipment, including imported high-performance liquid chromatographs, gas chromatographs, liquid chromatography-mass spectrometers, preparative high-performance liquid chromatographs, infrared spectrometers, diode array detectors, conductivity detectors, evaporative light scattering detectors, differential refractive index detectors, osmometers, dissolution testers, tablet presses, dry granulators, wet granulators, jet mills, nano grinders, laser particle size analyzers, extrusion-spheronization granulators, high-efficiency coating machines, fluidized beds, and fully automatic capsule filling machines.

70% of the company's employees hold master's or doctoral degrees, and over 90% have bachelor's degrees or higher. Additionally, the company has an academic advisory team composed of experts and professors. With strong pharmaceutical backgrounds and experience in drug research, development, and market transformation, the team is a united, pioneering, rigorous, and innovative group of professional elites.

The company focuses on developing blockbuster new drugs and generic drugs with clinical advantages and market potential. Its products cover major therapeutic areas such as cardiovascular and cerebrovascular diseases, anti-tumor drugs, antibiotics, antivirals, nervous system drugs, diabetes treatments, respiratory system drugs, and urinary system drugs. The company has developed dozens of products, with several having obtained production and clinical approvals. With a strong reputation and high-quality standards, the company has established long-term cooperative relationships with many large domestic pharmaceutical companies.

We adhere to a people-oriented philosophy, with technology as the core and foundation. Guided by the spirit of pursuing excellence and endless technological advancement, we focus on innovation in new drug development, striving to build the company into a top-tier R&D enterprise in China, enabling patients to access domestically produced high-quality drugs that match the quality of original research drugs.